Cargando…

Update in inclusion body myositis

PURPOSE OF REVIEW: The purpose of this study is to review recent scientific advances relating to the natural history, cause, treatment and serum and imaging biomarkers of inclusion body myositis (IBM). RECENT FINDINGS: Several theories regarding the aetiopathogenesis of IBM are being explored and ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Pedro, Brady, Stefen, Hanna, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2013
Materias:	MYOSITIS AND MYOPATHIES: Edited by Hector Chinoy and Robert G. Cooper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196838/ https://www.ncbi.nlm.nih.gov/pubmed/24067381 http://dx.doi.org/10.1097/01.bor.0000434671.77891.9a

Ejemplares similares

Update in juvenile myositis
por: Nistala, Kiran, et al.
Publicado: (2013)

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
por: Lilleker, James B, et al.
Publicado: (2019)

Exploring challenges in the management and treatment of inclusion body myositis
por: Skolka, Michael P., et al.
Publicado: (2023)

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
por: Rothwell, Simon, et al.
Publicado: (2019)

Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies
por: Kinder, Travis B., et al.
Publicado: (2020)

Ongoing Developments in Sporadic Inclusion Body Myositis
por: Machado, Pedro M., et al.
Publicado: (2014)

Update on muscle imaging in myositis
por: Tan, Ai Lyn, et al.
Publicado: (2023)

Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell–Deficient Milieu
por: Young, Nicholas A, et al.
Publicado: (2013)

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies
por: Zhou, Danlei, et al.
Publicado: (2023)

Novel myosin-based therapies for congenital cardiac and skeletal myopathies
por: Ochala, Julien, et al.
Publicado: (2016)

Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry‐Based Study
por: Espinosa‐Ortega, Fabricio, et al.
Publicado: (2022)

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
por: Wilkinson, Meredyth G Ll, et al.
Publicado: (2023)

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
por: Che, Weng Ian, et al.
Publicado: (2021)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
por: Chen, Xixia, et al.
Publicado: (2023)

Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis
por: Oto, Yohsuke, et al.
Publicado: (2023)

Severe case of rhabdomyolysis following jellyfish envenomation in the Mediterranean Sea
por: Buscetta, Giorgio, et al.
Publicado: (2023)

Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
por: Kawahata, Kimito, et al.
Publicado: (2023)

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study
por: Pijnenburg, Luc, et al.
Publicado: (2023)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2018)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis
por: Brady, Stefen, et al.
Publicado: (2014)

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
por: Rothwell, Simon, et al.
Publicado: (2019)

Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
por: Gang, Qiang, et al.
Publicado: (2014)

Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy()
por: Cortese, Andrea, et al.
Publicado: (2014)

Establishment of a Korea HPV cohort study
por: Lee, Won-Chul, et al.
Publicado: (2013)

The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2015)

Exercise in Myositis
por: Alexanderson, Helene
Publicado: (2018)

Inclusion body myositis: Update on the diagnostic and therapeutic landscape
por: Naddaf, Elie
Publicado: (2022)

Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies
por: Qin, Li, et al.
Publicado: (2021)

Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors
por: Armanini, Decio, et al.
Publicado: (2021)

Current Treatment for Myositis
por: Barsotti, Simone, et al.
Publicado: (2018)

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2016)

Inclusion body myositis: from genetics to clinical trials
por: Nagy, Sara, et al.
Publicado: (2022)

COVID-19 and Myositis: What We Know So Far
por: Saud, Ahmad, et al.
Publicado: (2021)

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan
por: Suzuki, Naoki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v5p7o1cr4hgen0jo3fe4tfcduf